<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN">
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=UTF-8">
    <title>Descriptions of participants</title>
    <link href="data:image/x-icon;base64,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" rel="icon" type="image/x-icon">
    <style>@import "https://fonts.googleapis.com/css?family=Source+Sans+Pro:ital,wgth:0,400;0,700;1,400;1,700";body {  font-family: "Source Sans Pro", sans-serif;  margin: 40px;}@media screen {  #backToTop {    position: fixed;    bottom: 0px;    left: 50%;    transform: translateX(-50%);    border-radius: 4px 4px 0 0;    padding: 4px 12px 4px 12px;    background: #1f3c73;    font-weight: bold;  }  #backToTop a {    color: white;  }}@media print {  #backToTop {    display: none;  }}table {  width: fit-content;  border-collapse: collapse;}th {  font-weight: bold;  background: LightGray;}td, th {  border: 1px solid LightGray;  padding: 8px;  font-size: 14px;  vertical-align: top;}caption {  font-weight: bold;  font-size: large;  text-align: left;  padding: 8px;}h1 {  font-size:38.5px;}h2 {  font-size:31.5px;}h1 small, h3 {  font-size:24.5px;}h2 small, h4 {  font-size:17.5px;}h3 small, h4 small, h5 {  font-size:14px;}h6 {  font-size:11.9px;}a {  color: #002d64;  text-decoration: none;}.byline {  font-weight: bold;  color: #002D64;}.disclaimer {  font-style: italic;}figure, table.analysis {  width: fit-content;  display: block;  margin-block-start: 1em;  margin-block-end: 1em;  margin-inline-start: 40px;  margin-inline-end: 40px;}thead tr td, th, figcaption, caption {  font-weight: bold;  background: LightGray;}span.inserted {  background-color: #e5ffcd;}span.deleted {  background-color: #e5ffcd;  text-decoration: line-through;}span.marker-yellow {  background-color: #ffff80;}ol ol {  list-style-type: lower-alpha;}ol ol ol {  list-style-type: lower-roman;}</style>
  </head>
  <body>
    <div class="logo">
      <svg xmlns="http://www.w3.org/2000/svg" height="57" viewBox="0 0 1138.5 192" width="338" xml:space="preserve">
        <path d="M86 .5v33a63.3 63.3 0 0 0 0 125v33a96 96 0 0 1 0-191zM106 .5v33a63.3 63.3 0 0 1 0 125v33a96 96 0 0 0 0-191z" fill="#1f3c73"></path>
        <path d="M93 0h6v192h-6z" fill="#a53995"></path>
        <path d="M93 0h6v192h-6zM82 44h8v6h-8z" fill="#a53995"></path>
        <path d="M63 58h40v6H63zM69 73h30v6H69zM78 86h36v6H78zM63 100h42v6H63zM60 114h28v6H60zM88 128h15v6H88zM84 140l6 6-6 6-6-6z" fill="#a53995"></path>
        <g aria-label="Cochrane" fill="#1f3c73" stroke-width="3.368">
          <path d="M256.96 82.722q-7.366 0-13.564-3.413-6.198-3.414-9.97-10.06-3.683-6.737-3.683-16.528 0-9.701 3.772-16.528 3.863-6.917 10.15-10.51 6.378-3.682 13.743-3.682 5.66 0 10.15 2.335 4.492 2.246 7.456 5.3l-7.007 8.443q-2.245-2.066-4.76-3.323-2.426-1.347-5.57-1.347-3.952 0-7.275 2.245-3.234 2.246-5.21 6.468-1.886 4.221-1.886 10.15 0 8.982 3.862 14.013 3.863 5.03 10.33 5.03 3.593 0 6.378-1.617 2.874-1.617 5.03-3.863l7.006 8.264q-7.365 8.624-18.953 8.624zM302.86 82.722q-5.659 0-10.689-2.695-4.94-2.784-7.994-7.994-3.054-5.3-3.054-12.665 0-7.456 3.054-12.665 3.054-5.21 7.994-7.905 5.03-2.784 10.689-2.784t10.599 2.784q4.94 2.695 7.994 7.905 3.054 5.21 3.054 12.665 0 7.365-3.054 12.665-3.054 5.21-7.994 7.994-4.94 2.695-10.599 2.695zm0-10.689q4.042 0 6.108-3.413 2.066-3.504 2.066-9.252 0-5.839-2.066-9.252-2.066-3.413-6.108-3.413-4.132 0-6.198 3.413-1.976 3.413-1.976 9.252 0 5.749 1.976 9.252 2.066 3.413 6.198 3.413zM352.98 82.722q-6.198 0-11.228-2.695-4.94-2.784-7.905-7.994-2.874-5.3-2.874-12.665 0-7.456 3.234-12.665 3.233-5.21 8.533-7.905 5.3-2.784 11.408-2.784 4.132 0 7.276 1.347 3.234 1.348 5.749 3.413l-6.198 8.534q-3.144-2.605-6.018-2.605-4.761 0-7.636 3.413-2.784 3.413-2.784 9.252 0 5.749 2.784 9.252 2.875 3.413 7.186 3.413 2.156 0 4.222-.898 2.066-.988 3.773-2.335l5.21 8.623q-3.324 2.874-7.186 4.132-3.863 1.167-7.546 1.167zM375.53 81.644V18.677h13.204v15.45l-.629 7.994q2.515-2.245 5.839-4.131 3.413-1.977 7.904-1.977 7.276 0 10.51 4.85 3.323 4.762 3.323 13.115v27.666h-13.204v-25.96q0-4.85-1.347-6.646-1.258-1.797-4.132-1.797-2.515 0-4.312 1.168-1.796 1.078-3.952 3.144v30.091zM426.82 81.644V37.091h10.779l.898 7.815h.36q2.425-4.491 5.838-6.647 3.413-2.246 6.827-2.246 1.886 0 3.144.27 1.257.18 2.156.628l-2.156 11.408q-1.168-.359-2.336-.539-1.078-.18-2.515-.18-2.515 0-5.3 1.887-2.694 1.797-4.49 6.288v25.869zM471.28 82.722q-6.108 0-9.701-3.862-3.593-3.953-3.593-9.612 0-7.006 5.928-10.959 5.929-3.952 19.133-5.3-.18-2.964-1.796-4.67-1.527-1.797-5.21-1.797-2.785 0-5.659 1.078-2.874 1.078-6.108 2.964l-4.76-8.713q4.221-2.605 8.982-4.222 4.85-1.616 10.06-1.616 8.533 0 13.114 4.94 4.58 4.94 4.58 15.18v25.51h-10.778l-.898-4.581h-.36q-2.784 2.515-6.018 4.132-3.144 1.527-6.916 1.527zm4.491-10.24q2.246 0 3.863-.988 1.706-1.078 3.413-2.785v-7.814q-7.006.898-9.701 2.874-2.695 1.886-2.695 4.491 0 2.156 1.348 3.234 1.437.988 3.772.988zM507.39 81.644V37.091h10.779l.898 5.659h.36q2.874-2.695 6.287-4.671 3.503-2.066 7.995-2.066 7.275 0 10.509 4.85 3.323 4.761 3.323 13.115v27.666h-13.204v-25.96q0-4.85-1.347-6.646-1.258-1.797-4.132-1.797-2.515 0-4.312 1.168-1.796 1.078-3.952 3.144v30.09zM578.71 82.722q-6.378 0-11.498-2.785-5.12-2.784-8.084-7.994-2.964-5.21-2.964-12.575 0-7.276 2.964-12.486 3.054-5.21 7.904-7.994 4.85-2.875 10.15-2.875 6.378 0 10.51 2.875 4.221 2.784 6.287 7.635 2.156 4.76 2.156 10.869 0 1.706-.18 3.413-.18 1.617-.36 2.425h-26.677q.898 4.85 4.042 7.186 3.144 2.246 7.545 2.246 4.761 0 9.612-2.964l4.4 7.994q-3.412 2.335-7.634 3.683-4.222 1.347-8.174 1.347zm-9.88-28.205h16.078q0-3.683-1.796-6.018-1.707-2.426-5.66-2.426-3.053 0-5.479 2.156-2.425 2.066-3.143 6.288z"></path>
        </g>
        <g aria-label="Library" fill="#a53995" stroke-width="3.368">
          <path d="M236.48 168.68v-58.925h7.455v52.547h25.78v6.378zM279.42 168.68v-43.655h7.366v43.655zm3.773-52.637q-2.156 0-3.593-1.258-1.348-1.347-1.348-3.593 0-2.155 1.348-3.503 1.437-1.347 3.593-1.347 2.155 0 3.503 1.347 1.437 1.348 1.437 3.503 0 2.246-1.437 3.593-1.348 1.258-3.503 1.258zM320.82 169.76q-3.054 0-6.378-1.437-3.233-1.527-6.108-4.132h-.27l-.628 4.491h-5.928v-63.955h7.365v17.426l-.18 7.905q2.965-2.605 6.468-4.312 3.593-1.796 7.186-1.796 8.533 0 12.935 6.018 4.401 6.018 4.401 16.168 0 7.455-2.694 12.755-2.605 5.3-6.917 8.084-4.222 2.785-9.252 2.785zm-1.258-6.198q5.39 0 8.893-4.58 3.593-4.672 3.593-12.756 0-7.186-2.695-11.587-2.605-4.491-8.803-4.491-2.784 0-5.659 1.527-2.874 1.527-6.018 4.401v22.905q2.875 2.515 5.66 3.593 2.874.988 5.03.988zM351.19 168.68v-43.655h6.108l.629 7.905h.27q2.245-4.132 5.479-6.558 3.233-2.425 6.916-2.425 2.605 0 4.671.898l-1.437 6.468q-1.078-.36-1.976-.54-.899-.179-2.246-.179-2.784 0-5.838 2.246-2.965 2.245-5.21 7.814v28.025zM390.26 169.76q-5.48 0-9.162-3.234-3.593-3.323-3.593-9.162 0-7.186 6.377-10.959 6.468-3.862 20.39-5.39 0-2.784-.808-5.299-.719-2.515-2.695-4.042-1.886-1.617-5.479-1.617-3.773 0-7.096 1.437-3.324 1.438-5.928 3.234l-2.875-5.12q3.054-1.976 7.456-3.773 4.49-1.886 9.7-1.886 7.995 0 11.588 4.94 3.593 4.851 3.593 13.026v26.768h-6.108l-.63-5.21h-.269q-3.054 2.515-6.736 4.401-3.593 1.886-7.725 1.886zm2.156-5.928q3.144 0 5.928-1.527 2.785-1.527 5.929-4.312v-12.126q-10.87 1.347-15.27 4.042-4.312 2.695-4.312 6.917 0 3.682 2.246 5.39 2.245 1.616 5.479 1.616zM425.47 168.68v-43.655h6.108l.629 7.905h.27q2.245-4.132 5.479-6.558 3.233-2.425 6.916-2.425 2.605 0 4.671.898l-1.437 6.468q-1.078-.36-1.976-.54-.898-.179-2.246-.179-2.784 0-5.838 2.246-2.965 2.245-5.21 7.814v28.025zM459.6 187.45q-1.437 0-2.785-.27-1.257-.269-2.335-.628l1.437-5.839q.719.18 1.617.36.898.269 1.707.269 3.683 0 6.108-2.695 2.425-2.605 3.772-6.647l.988-3.233-17.516-43.745h7.636l8.892 24.163q.988 2.784 2.066 6.018 1.168 3.233 2.156 6.287h.36q.987-2.964 1.886-6.197.898-3.234 1.796-6.109l7.815-24.163h7.186l-16.438 47.248q-1.527 4.312-3.683 7.725-2.066 3.414-5.21 5.39-3.054 2.066-7.455 2.066z"></path>
        </g>
        <g aria-label="Trusted evidence." fill="#1f3c73" stroke-width="3.368">
          <path d="M710.25 61.723V30.141h-10.671v-3.773h25.869v3.773h-10.671v31.582zM728.9 61.723V35.53h3.665l.377 4.743h.162q1.347-2.48 3.287-3.935t4.15-1.455q1.563 0 2.803.54l-.863 3.88q-.646-.216-1.185-.324-.54-.108-1.348-.108-1.67 0-3.503 1.348-1.778 1.347-3.126 4.689v16.815zM755.25 62.37q-4.15 0-6.09-2.587-1.94-2.64-1.94-7.653v-16.6h4.473v16.007q0 3.665 1.132 5.336 1.185 1.67 3.772 1.67 2.048 0 3.611-1.024 1.617-1.078 3.45-3.395V35.53h4.42v26.193h-3.666l-.377-4.096h-.162q-1.832 2.156-3.88 3.45-2.048 1.293-4.743 1.293zM783.76 62.37q-2.803 0-5.336-1.024-2.533-1.078-4.419-2.587l2.21-2.964q1.724 1.347 3.557 2.263 1.832.863 4.15.863 2.587 0 3.88-1.186 1.294-1.24 1.294-2.91 0-1.348-.917-2.264-.862-.916-2.263-1.509-1.348-.647-2.803-1.186-1.832-.7-3.61-1.562-1.78-.917-2.911-2.318-1.132-1.455-1.132-3.665 0-3.18 2.372-5.281 2.425-2.156 6.683-2.156 2.425 0 4.527.862t3.61 2.102l-2.155 2.802q-1.347-1.024-2.803-1.67-1.455-.647-3.18-.647-2.479 0-3.664 1.132-1.132 1.132-1.132 2.64 0 1.24.809 2.049.808.754 2.101 1.347 1.294.539 2.749 1.132 1.886.7 3.719 1.617 1.832.862 3.018 2.371 1.24 1.455 1.24 3.934 0 2.102-1.132 3.88-1.078 1.78-3.234 2.857-2.102 1.078-5.228 1.078zM806.67 62.37q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306V39.141h-3.88V35.8l4.095-.27.54-7.33h3.718v7.33h7.06v3.61h-7.06v14.553q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.509-.216l1.455-.485.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM826.5 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.071-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.562 2.91q-1.67 1.078-3.826 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM851.56 62.37q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V23.35h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61V41.35q-1.67-1.509-3.234-2.102-1.509-.646-3.126-.646-2.101 0-3.826 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.69 1.886 7.384 1.887 2.64 5.336 2.64zM893.92 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743t-1.67-7.33q0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.706 3.341 2.75 3.342 2.75 8.947 0 .7-.055 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.796.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.959 2.156-2.155 2.102-2.587 5.982zM915.97 61.723l-9.432-26.193h4.581l4.959 14.875 1.185 3.88q.647 1.94 1.24 3.827h.216q.592-1.886 1.185-3.827.647-1.94 1.186-3.88l4.958-14.875h4.366l-9.27 26.193zM935.48 61.723V35.53h4.42v26.193zm2.264-31.582q-1.294 0-2.156-.755-.809-.808-.809-2.155 0-1.294.809-2.102.862-.809 2.156-.809 1.293 0 2.101.809.863.808.863 2.102 0 1.347-.862 2.155-.809.755-2.102.755zM957.68 62.37q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V23.35h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61V41.35q-1.67-1.509-3.234-2.102-1.509-.646-3.126-.646-2.101 0-3.826 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.69 1.887 7.384 1.886 2.64 5.335 2.64zM989.26 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743t-1.67-7.33q0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM1005.4 61.723V35.53h3.665l.377 3.773h.162q1.886-1.887 3.988-3.126 2.102-1.294 4.797-1.294 4.15 0 6.036 2.641 1.94 2.587 1.94 7.6v16.6h-4.42V45.715q0-3.665-1.185-5.335t-3.773-1.671q-1.994 0-3.61 1.024-1.563 1.024-3.558 3.018v18.971zM1045.2 62.37q-3.45 0-6.252-1.617t-4.42-4.689q-1.616-3.072-1.616-7.383 0-4.42 1.725-7.492 1.778-3.072 4.635-4.688 2.91-1.617 6.251-1.617 2.587 0 4.42.916 1.886.916 3.233 2.156l-2.263 2.91q-1.132-1.024-2.425-1.67-1.24-.647-2.803-.647-2.371 0-4.258 1.293-1.832 1.24-2.91 3.557-1.024 2.264-1.024 5.282 0 4.473 2.21 7.276 2.263 2.748 5.874 2.748 1.833 0 3.396-.754 1.563-.809 2.748-1.887l1.94 2.965q-1.778 1.563-3.934 2.479-2.156.862-4.527.862zM1068.9 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.071-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.707 3.341 2.748 3.342 2.748 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.678q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.724-6.036-1.671-2.102-4.743-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM1087.4 62.37q-1.347 0-2.317-.916-.917-.97-.917-2.426 0-1.562.917-2.479.97-.97 2.317-.97 1.294 0 2.21.97.97.916.97 2.48 0 1.455-.97 2.425-.916.916-2.21.916z"></path>
        </g>
        <g aria-label="Informed decisions." fill="#1f3c73" stroke-width="3.368">
          <path d="M699.58 124.7V89.345h4.473V124.7zM713.32 124.7V98.507h3.665l.377 3.773h.162q1.886-1.887 3.988-3.126 2.102-1.294 4.797-1.294 4.15 0 6.036 2.641 1.94 2.587 1.94 7.6v16.6h-4.42v-16.008q0-3.665-1.185-5.335-1.186-1.671-3.773-1.671-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018V124.7zM743.56 124.7v-22.582h-3.557v-3.341l3.557-.27v-4.15q0-3.988 1.832-6.306 1.887-2.371 5.821-2.371 1.24 0 2.371.27 1.132.215 1.995.592l-.97 3.396q-1.456-.647-2.965-.647-3.665 0-3.665 5.066v4.15h5.552v3.61h-5.552V124.7zM768.19 125.35q-3.18 0-5.982-1.617-2.749-1.617-4.474-4.689-1.67-3.072-1.67-7.383 0-4.42 1.67-7.492 1.725-3.072 4.474-4.688 2.802-1.617 5.982-1.617 3.234 0 5.982 1.617 2.749 1.616 4.42 4.688 1.724 3.072 1.724 7.492 0 4.311-1.724 7.383-1.671 3.072-4.42 4.69t-5.982 1.616zm0-3.665q3.395 0 5.443-2.748 2.102-2.803 2.102-7.276 0-4.527-2.102-7.33-2.048-2.802-5.443-2.802-3.341 0-5.443 2.802t-2.102 7.33q0 4.473 2.102 7.276 2.102 2.748 5.443 2.748zM787.21 124.7V98.507h3.665l.377 4.743h.162q1.347-2.48 3.287-3.935t4.15-1.455q1.563 0 2.803.54l-.863 3.88q-.646-.216-1.185-.324-.54-.108-1.348-.108-1.67 0-3.503 1.348-1.778 1.347-3.126 4.689V124.7zM805.91 124.7V98.507h3.665l.377 3.773h.162q1.724-1.887 3.772-3.126 2.048-1.294 4.366-1.294 3.018 0 4.689 1.348 1.724 1.293 2.533 3.664 2.048-2.21 4.15-3.61 2.101-1.402 4.473-1.402 4.042 0 5.982 2.641 1.994 2.587 1.994 7.6v16.6h-4.42v-16.008q0-3.665-1.185-5.335-1.186-1.671-3.665-1.671-2.91 0-6.575 4.042V124.7h-4.42v-16.007q0-3.665-1.185-5.336-1.186-1.67-3.719-1.67-2.91 0-6.575 4.042v18.97zM861.21 125.35q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.071-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.562 2.91q-1.67 1.078-3.826 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.724-6.036-1.671-2.102-4.743-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM886.27 125.35q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V86.33h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61v-13.69q-1.67-1.509-3.234-2.102-1.509-.646-3.126-.646-2.101 0-3.826 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.689 1.886 7.384 1.887 2.64 5.336 2.64zM926.96 125.35q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V86.33h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61v-13.69q-1.67-1.509-3.234-2.102-1.509-.646-3.125-.646-2.102 0-3.827 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.689 1.887 7.384 1.886 2.64 5.335 2.64zM958.54 125.35q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743t-1.67-7.33q0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.959 2.156-2.155 2.102-2.587 5.982zM985.01 125.35q-3.45 0-6.252-1.617-2.802-1.617-4.42-4.689-1.616-3.072-1.616-7.383 0-4.42 1.725-7.492 1.778-3.072 4.635-4.688 2.91-1.617 6.251-1.617 2.587 0 4.42.916 1.886.916 3.233 2.156l-2.263 2.91q-1.132-1.024-2.425-1.67-1.24-.647-2.803-.647-2.371 0-4.258 1.293-1.832 1.24-2.91 3.557-1.024 2.264-1.024 5.282 0 4.473 2.21 7.276 2.263 2.748 5.874 2.748 1.833 0 3.396-.754 1.563-.809 2.748-1.887l1.94 2.965q-1.778 1.563-3.934 2.479-2.156.862-4.527.862zM999.23 124.7V98.507h4.42V124.7zm2.264-31.582q-1.294 0-2.156-.755-.809-.808-.809-2.155 0-1.294.809-2.102.862-.809 2.156-.809 1.293 0 2.101.809.863.808.863 2.102 0 1.347-.862 2.155-.809.755-2.102.755zM1019.3 125.35q-2.803 0-5.336-1.024-2.533-1.078-4.419-2.587l2.21-2.964q1.724 1.347 3.557 2.263 1.832.863 4.15.863 2.587 0 3.88-1.186 1.293-1.24 1.293-2.91 0-1.348-.916-2.264-.862-.916-2.263-1.509-1.348-.647-2.803-1.185-1.832-.701-3.61-1.563-1.78-.917-2.911-2.318-1.132-1.455-1.132-3.665 0-3.18 2.371-5.281 2.426-2.156 6.683-2.156 2.426 0 4.528.862 2.101.862 3.61 2.102l-2.155 2.803q-1.348-1.024-2.803-1.671-1.455-.647-3.18-.647-2.479 0-3.664 1.132-1.132 1.132-1.132 2.64 0 1.24.808 2.049.809.754 2.102 1.347 1.294.539 2.749 1.132 1.886.7 3.718 1.617 1.833.862 3.019 2.371 1.24 1.455 1.24 3.934 0 2.102-1.133 3.88-1.078 1.78-3.233 2.857-2.102 1.078-5.228 1.078zM1035.1 124.7V98.507h4.42V124.7zm2.264-31.582q-1.294 0-2.156-.755-.809-.808-.809-2.155 0-1.294.809-2.102.862-.809 2.156-.809t2.101.809q.863.808.863 2.102 0 1.347-.863 2.155-.808.755-2.101.755zM1058.5 125.35q-3.18 0-5.982-1.617-2.749-1.617-4.474-4.689-1.67-3.072-1.67-7.383 0-4.42 1.67-7.492 1.725-3.072 4.474-4.688 2.802-1.617 5.982-1.617 3.234 0 5.982 1.617 2.749 1.616 4.42 4.688 1.724 3.072 1.724 7.492 0 4.311-1.724 7.383-1.671 3.072-4.42 4.69-2.748 1.616-5.982 1.616zm0-3.665q3.395 0 5.443-2.748 2.102-2.803 2.102-7.276 0-4.527-2.102-7.33-2.048-2.802-5.443-2.802-3.341 0-5.443 2.802t-2.102 7.33q0 4.473 2.102 7.276 2.101 2.748 5.443 2.748zM1077.5 124.7V98.507h3.665l.377 3.773h.162q1.886-1.887 3.988-3.126 2.102-1.294 4.797-1.294 4.15 0 6.036 2.641 1.94 2.587 1.94 7.6v16.6h-4.42v-16.008q0-3.665-1.185-5.335-1.186-1.671-3.773-1.671-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018V124.7zM1113.9 125.35q-2.803 0-5.336-1.024-2.533-1.078-4.419-2.587l2.21-2.964q1.724 1.347 3.557 2.263 1.832.863 4.15.863 2.587 0 3.88-1.186 1.293-1.24 1.293-2.91 0-1.348-.916-2.264-.862-.916-2.263-1.509-1.348-.647-2.803-1.185-1.832-.701-3.61-1.563-1.78-.917-2.911-2.318-1.132-1.455-1.132-3.665 0-3.18 2.372-5.281 2.425-2.156 6.683-2.156 2.425 0 4.527.862 2.102.862 3.61 2.102l-2.155 2.803q-1.348-1.024-2.803-1.671-1.455-.647-3.18-.647-2.479 0-3.664 1.132-1.132 1.132-1.132 2.64 0 1.24.808 2.049.809.754 2.102 1.347 1.294.539 2.749 1.132 1.886.7 3.718 1.617 1.833.862 3.019 2.371 1.24 1.455 1.24 3.934 0 2.102-1.133 3.88-1.078 1.78-3.233 2.857-2.102 1.078-5.228 1.078zM1131.9 125.35q-1.347 0-2.317-.916-.917-.97-.917-2.426 0-1.562.917-2.479.97-.97 2.317-.97 1.294 0 2.21.97.97.916.97 2.48 0 1.455-.97 2.425-.916.916-2.21.916z"></path>
        </g>
        <g aria-label="Better health." fill="#a53995" stroke-width="3.368">
          <path d="M699.58 187.95v-35.355h10.509q3.61 0 6.306.862 2.748.863 4.257 2.749 1.563 1.886 1.563 5.012 0 2.64-1.347 4.797-1.294 2.102-3.827 2.91v.216q3.18.592 5.174 2.694 2.048 2.102 2.048 5.767 0 3.45-1.724 5.767-1.671 2.317-4.69 3.449-3.017 1.132-7.005 1.132zm4.473-20.318h5.228q4.527 0 6.521-1.563 1.994-1.563 1.994-4.258 0-3.072-2.101-4.365-2.048-1.294-6.198-1.294h-5.444zm0 16.761h6.144q4.581 0 7.114-1.67 2.533-1.725 2.533-5.282 0-3.288-2.533-4.797-2.479-1.563-7.114-1.563h-6.144zM741.46 188.6q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.072-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.706 3.341 2.75 3.342 2.75 8.947 0 .7-.055 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.796.808zm-8.246-15.845h14.013q0-3.988-1.724-6.036-1.671-2.102-4.743-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM765.28 188.6q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306v-14.498h-3.88v-3.341l4.095-.27.54-7.33h3.718v7.33h7.06v3.611h-7.06v14.552q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.51-.215l1.454-.486.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM782.42 188.6q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306v-14.498h-3.88v-3.341l4.095-.27.54-7.33h3.718v7.33h7.06v3.611h-7.06v14.552q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.51-.215l1.454-.486.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM802.25 188.6q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.072-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.562 2.91q-1.67 1.078-3.826 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM818.36 187.95v-26.193h3.665l.377 4.743h.162q1.347-2.48 3.287-3.935t4.15-1.455q1.563 0 2.803.54l-.863 3.88q-.646-.216-1.185-.324t-1.348-.108q-1.67 0-3.503 1.348-1.778 1.347-3.126 4.689v16.815zM847.84 187.95v-38.373h4.42v10.456l-.162 5.39q1.886-1.779 3.934-3.019 2.102-1.293 4.797-1.293 4.15 0 6.036 2.64 1.94 2.588 1.94 7.6v16.6h-4.42v-16.007q0-3.665-1.185-5.336-1.186-1.67-3.773-1.67-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018v18.97zM887.78 188.6q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.072-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.706 3.341 2.75 3.342 2.75 8.947 0 .7-.055 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.796.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.959 2.156-2.155 2.102-2.586 5.982zM909.18 188.6q-3.288 0-5.497-1.94-2.156-1.994-2.156-5.498 0-4.311 3.826-6.575 3.88-2.317 12.234-3.233 0-1.671-.485-3.18-.43-1.51-1.616-2.426-1.132-.97-3.288-.97-2.264 0-4.258.863-1.994.862-3.557 1.94l-1.724-3.072q1.832-1.186 4.473-2.264 2.695-1.131 5.82-1.131 4.797 0 6.953 2.964 2.156 2.91 2.156 7.814v16.061h-3.665l-.377-3.125h-.162q-1.832 1.509-4.042 2.64-2.156 1.132-4.635 1.132zm1.294-3.557q1.886 0 3.556-.916 1.671-.916 3.557-2.587v-7.276q-6.52.808-9.162 2.425-2.587 1.617-2.587 4.15 0 2.21 1.348 3.234 1.347.97 3.287.97zM934.99 188.6q-2.48 0-3.61-1.509-1.079-1.563-1.079-4.42v-33.09h4.42v33.415q0 1.024.377 1.509.377.43.862.43h.377q.216-.053.593-.107l.593 3.341q-.431.216-1.024.324-.593.108-1.509.108zM952.29 188.6q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306v-14.498h-3.88v-3.341l4.095-.27.54-7.33h3.718v7.33h7.06v3.611h-7.06v14.552q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.51-.215l1.454-.486.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM962.26 187.95v-38.373h4.42v10.456l-.162 5.39q1.886-1.779 3.934-3.019 2.102-1.293 4.797-1.293 4.15 0 6.036 2.64 1.94 2.588 1.94 7.6v16.6h-4.42v-16.007q0-3.665-1.185-5.336-1.186-1.67-3.773-1.67-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018v18.97zM993.9 188.6q-1.347 0-2.317-.916-.917-.97-.917-2.426 0-1.563.916-2.479.97-.97 2.318-.97 1.294 0 2.21.97.97.917.97 2.48 0 1.455-.97 2.425-.917.916-2.21.916z"></path>
        </g>
      </svg>
    </div>
    <h1>Supplementary material 24 to: Daily iron supplementation for prevention or treatment of iron deficiency anaemia in infants, children, and adolescents</h1>
    <p>
      <span class="byline">Rajagopalan K, Hackl L, Pe&ntilde;a-Rosas JP, Garcia-Casal MN, Rizal M, Mehta NH, Roudik M, Islam S, Trumbull-Kennedy MM, Khondakar NR, Franco JVA, Finkelstein JL, Mehta S</span>
      <br>
      <span class="doi"><a href="https://doi.org/10.1002/14651858.CD013227.pub2">https://doi.org/10.1002/14651858.CD013227.pub2</a></span>
    </p>
    <p>
      <span class="disclaimer">The material in this section has been supplied by the author(s) for publication under a Licence for Publication and the author(s) are solely responsible for the material. Cochrane has reviewed this material, but Cochrane has not copyedited, formatted or proofread. Cochrane accordingly gives no representations or warranties of any kind in relation to, and accepts no liability for any reliance on or use of, such material.</span>
    </p>
    <div id="backToTop">
      <a href="#top">Back to top</a>
    </div>
    <h1>Descriptions of participants</h1>
    <div>
      <table>
        <tr>
          <th style="vertical-align: top;">
            <p>Trial ID</p>
          </th><th style="vertical-align: top;">
            <p>Criteria</p>
          </th><th style="vertical-align: top;">
            <p>Description</p>
          </th>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Amirsasan 2024</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>Willing to participate in the study</li>
              <li>Not having specifc blood diseases such as thalassemia, digestive problems, and menstrual disorders and not being allergic to sumac</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>Injury during exercise</li>
              <li>taking any type of medicine or supplement</li>
              <li>missing more than two sessions of training</li>
              <li>irregular consumption of the supplements</li>
              <li>under investigation, or intolerance of ferrous sulfate supplements.</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p>low iron stores (ferritin below 40 ng/ml), normal hemoglobin (above 12 g/dL), </p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Lal 2024</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Long 2024</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>Aged 6&minus;12 years at baseline, attended grades 1&minus;4 and did not have clini- cal conditions preventing participation in physical edu- cation lessons</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>Children Had gastro-intestinal tract alterations impairing MMNS absorption or had received food/micronutrient supplements in the past 6 months.</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Svensson 2024</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>healthy singleton infants born at term (37-42 weeks&rsquo; gestation, birth weight &gt;2500 g)</li>
              <li>exclusively or predominantly breastfed (&gt;50% of daily feedings)</li>
              <li>did not have anemia (&gt;10.5 g/dL; to convert to g/L, multiply by 10) at age 4 months</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>Major illness, congenital anomalies, food allergies, or communication difficulties with caregivers.</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p>Birth weight &gt;2500 g, anemia (&lt;=10.5 g/dL)</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Csulak 2023</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>male athletes, age under 19 years, no previously known cardiovascular disease, athletes with ID defined as ferritin level &lt;100 μg/L (for the randomized placebo‐controlled study)</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>clinical or laboratory sign of infection or inflammation</li>
              <li>underlying cardiovascular disease detected on the screening exam</li>
              <li>athletes, who left the Basketball Academy and could not participate in the control exam</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p> ID defined as ferritin level &lt;100 μg/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Varea 2023</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>clinically healthy; infants born at "term with a birth weight of more than 2500 g and less than 4000 g, with a cord clamping time greater than 30 seconds, normal fetal-neonatal history, whose parents or legal guardians agreed to participate in the study". </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>"Infants with anemia at study initiation, with chronic conditions or acute infections in the 15 days prior to the study, or receiving antibiotic therapy or iron supplementation"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>anaemia at 3 months: haemoglobin &lt; 9.5 g/dL</li>
              <li>anaemia at 6 months: haemoglobin &lt; 11 g/dL </li>
              <li>ID: ferritin &lt; 12 ng/mL</li>
              <li>ID in the presence of inflammation (C-reactive protein &ge; 5 mg/L): &lt;30 ng/mL</li>
              <li>IDA: haemoglobin &lt; 11g/dL and ferritin &lt; 12 ng/mL</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Pongpitakdamrong 2022</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>"Children and adolescents aged 6 to 18 years, who met Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 diagnostic criteria of attention-deficit/hyperactivity disorder (ADHD) and were treated with a steady dosage of methylphenidate for at least 1 month, were invited to participate in this study...Participants with iron deficiency (either serum ferritin level &lt;30 mg/dL or transferrin saturation [serum iron/total iron binding capacity] &lt;16%) were randomized"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>"established diagnosis of intellectual disability, anemic symptoms, hematocrit &lt;30%, and currently taking iron supplementation. Patients with anemic symptoms and hematocrit &lt;30% were excluded because of ethical issues. Children who were taking vitamins containing iron were excluded to prevent contamination of the other source of iron to the placebo group"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p>ID: "serum ferritin level &lt;30 mg/dL or transferrin saturation (serum iron/total iron binding capacity x 100)"</p>
            <p>"ADHD symptoms by parents and teachers using 2 parts of the Vanderbilt Attention-Deficit/Hyperactivity Disorder Diagnostic Rating Scales...higher score denoting more severe ADHD."</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Stelle 2022</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>"infants (male or female) aged between 6&ndash;10 weeks. Infants must be exclusively breastfed with plans to continue breastfeeding through six months of age. Parents/guardians (with the participant) must reside in the study site area and be able and willing to adhere to all protocol visits and procedures. Infants must be healthy with no current illness and no chronic health problems. Informed consent must be obtained from the participants parent/guardian. Low birth weight infants (less than 2.5kg at birth) or infants born prematurely (less than 37 weeks) will be included."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>"formula fed infants or those whose parents/guardians are planning to use commercially available infant formula before six months of age. Infants may not have acute illness, however, once acute illness is resolved, participants may be re-revaluated for eligibility. Infants with fever (a body temperature greater than 37.5&deg;C or mother report of fever) within three days prior to randomisation will be excluded (once fever/acute illness is resolved, participant may be re-revaluated for eligibility). Infants of parents/guardians unwilling for their infant to avoid the ingestion of supplements or herbal/other traditional medications during the study period will be excluded. Infants with any history of, or evidence for, a chronic clinically significant disorder or disease (including, but not limited to, immunodeficiency, autoimmunity, congenital abnormality, bleeding disorder, and pulmonary, cardiovascular, metabolic, neurologic, renal, or hepatic disease), self-reported history suggestive of meningitis, seizures, Guillain-Barr&eacute; syndrome, or other neurological disorders, or any condition that in the opinion of the investigator may compromise the safety or well-being of the participant or compromise adherence to protocol procedures, will be excluded."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Hoang 2021</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>Primary school children aged 6-9 years</li>
              <li>Apparently healthy</li>
              <li>Haemoglobin concentration &lt;110 g/L</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>Haemoglobin concentration &lt;70 g/L</li>
              <li>Current/planned vitamin and mineral supplementation</li>
              <li>Chronic disease</li>
              <li>Chronic infection</li>
              <li>Congenital abnormality</li>
              <li>Severe malnutrition</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p>Hb (&lt;110 g/L for inclusion, &lt;70 g/L for exclusion)</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Zečkanović 2021</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>"children aged nine months to six years were screened for eligibility during regular health check-up visits...included only children with iron deficiency presenting either without anemia or with mild microcytic hypochromic anemia not requiring medication"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>"any child with anemia that was not due to iron deficiency, any child with known allergies to any of the ingredients of &gt;Your&lt; Iron Syrup, any child with chronic disease and any child with a medical, mental, or physical state that, in the opinion of the investigator, would be incompatible with taking the investigational product or with the course of the study. Vegans and those already taking iron-containing dietary supplements or medications were also excluded from participation, as well as those taking part in another clinical study at screening or less than one month before screening."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p>"mild microcytic hypochromic anemia not requiring medication": ferritin level &le; 20 &micro;g/L and hemoglobin (Hb) &ge; 100 g/L in a capillary blood sample; ID: ferritin &gt; 20 &micro;g/L; "mild anemia as defined by a Hb level of less than 110 g/L (below 5 years of age) or 115 g/L (above 5 years of age) [[<a href="#404935757088486172">1</a>]]."</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Tohidi 2021</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>"All participants were... under the treatment of methyl-phenidate, with associated ferritin levels below 30 ng/ml and absence of anemia (defined as hemoglobin levels less than 11 g/dl)... all patients were under the treatment of short-acting form of methylphenidate (Ritalin-by Novartis Pharmaceuticals Corporation) and methylphenidate was matched in both groups in terms of dosage and duration, before entering the study."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>"Children with mental disorders along with ADHD, se-vere chronic medical conditions (i.e., malnutrition), men-tal retardation and other psychiatric comorbidities (such as anxiety; by diagnostic interview of an expert psychia-trist and according to DSM-IV), inflammation or infection, taking medications other than methylphenidate including catecholamines, use of iron supplementation over the past three months, having contraindication of iron supple-mentation, severe fever (due to the false increase in the level of ferritin), and hypothyroidism were excluded from the study."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p>"ADHD was diagnosed by diagnostic inter-view of the corresponding psychiatrist and based on the clinical criteria of Diagnostic and Statistical Manual of Mental Disorders 4th edition, text revision (DSM-IV-TR) [<a href="#433465774834182469">2</a>]."</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Pasricha 2021</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>"We screened children 7.5 to 8.5 months of age."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>"Children with marked anemia (a hemoglobin level of &lt;8.0 g per deciliter), current febrile illness, severe acute malnutrition, a known inherited red-cell disorder or previous transfusion, or known developmental delay were excluded... Furthermore, iron levels in drinking water were tested at screening, and children were excluded if the level exceeded 1 mg per liter."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p>Anaemia: Hb &lt; 11 g/dL; ID: ferritin &lt; 12 μg/L or &lt; 30 μg/L if CRP &gt; 5 mg/L; IDA: concurrent anaemia and ID</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Parkin 2021</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>"Children were included if they were 12-40 months of age and met criteria for nonanemic iron deﬁciency, deﬁned as: hemoglobin &ge; 110 g/L and serum ferritin &lt; 14 mg/L." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>"Children were excluded if they had a developmental, genetic, or chronic condition (with the exception of asthma and allergies); gesta-tional age &lt; 35 weeks; birth weight &lt; 2500 g; acute illness; attending for other than health supervision; English not spoken at home or child care; previous anemia or iron deﬁciency; receiving any iron containing product; contraindications to receiving iron; CRP &ge; 10 mg/L or missing (elevated CRP suggests inﬂammation which may falsely elevate serum ferritin)."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p>non-anaemic iron deﬁciency: hemoglobin &ge; 110 g/L and serum ferritin &lt; 14 mg/L.</p>
          </td>
        </tr>
        <tr>
          <td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>Reynolds 2020<br>  
            </p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria<br>  
            </p>
          </td><td style="vertical-align: top;">
            <p>"a diagnosis of ASD [(autism spectrum disorder), based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision criteria, [<a href="#422043425252513842">3</a>]) and a confirmatory Autism Diagnostic Observation Schedule, [<a href="#422043526866081846">4</a>]], age two to 10 years, insomnia defined by parent report of sleep onset delay of 40 minutes or greater on three or more nights per week or night waking at least three times per week requiring parental intervention or lasting more than 20 minutes per night, and serum ferritin less than 50 ng/mL but greater than 17 ng/mL....children were eligible for enrollment if they met criteria for insomnia by actigraphy...Children with coexisting medical, psychiatric, and neurological disorders were included if they had been evaluated by a physician and a treatment plan had been implemented, with the child on a stable dose of medication for at least one month. Children with known genetic syndromes were included if they met other eligibility criteria."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria<br>  
            </p>
          </td><td style="vertical-align: top;">
            <p>poorly controlled constipation, obstructive sleep apnea, seizures within 2 y, use of antinausea drugs or typical antipsychotics that may impact restless legs syndrome, use of drugs that have an interaction with iron, girls who had achieved menarche, family history of haemochromatosis, poorly managed medical conditions that affect sleep such as gastrooesophageal reflux or severe eczema, current treatment with iron, allergy to turmeric (a natural dye in the placebo), onset of sleep issues temporally related to onset of puberty or initiation of a medication known to affect sleep, enrolment in another intervention study unless the study was of long-term educational interventions with no changes planned during the study, inability to wear actigraphy watch</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria<br>  
            </p>
          </td><td style="vertical-align: top;">
            <p>"...serum ferritin...lower limit of normal for the central laboratory was 17 ng/mL...equivalent to a clinical laboratory value of 10 ng/mL...</p>
            <p>actigraphy...defined as an average sleep onset latency (SOL) greater than 30 minutes or an average wake time after sleep onset (WASO) greater than 45 minutes per night, or sleep diary confirmation of night waking criteria"</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Bora 2019</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>vaginal or Caesarean delivered singleton term (37 to 41 wk) neonates born to women who were nonsmokers, no haemolytic disease,not on medications (e.g. antidepressants, anticonvulsants, thyroid hormone, chemotherapeutic agents or steroids), no obstetrical problems (e.g. diabetes mellitus, pre-eclampsia or rupture of membranes &gt; 24 h prior to delivery),<br> residing within 100 km from the institution, infants delivered by vaginal or caesarean delivery</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants: Rh incompatibility, presence of lethal congenital malformations or syndromes, illness needing Neonatal Intensive Care Unit admission, cord blood CRP &gt; 6 mg/dL</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &le; 100 g/L</p>
            <p>ID: serum ferritin &lt; 12 ng/mL</p>
            <p>ID anaemia: haemoglobin &lt; 110 g/L and serum ferritin &lt; 12 ng/mL</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Johnstone 2019</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>6&ndash;12 years old at the time of enrollment</li>
              <li>willing/able to swallow 9&ndash;12 capsules per day with food and attend all study appointments to complete questionnaires</li>
              <li>meet criteria for ADHD as assessed by the CASI-5, with symptoms present in more than one setting and causing impairment in social or academic functioning</li>
              <li>have at least one symptom of irritability or anger from the ODD or DMDD subscale questions</li>
              <li>be medication-free, or washed out for at least 2 weeks prior to in-person baseline assessment (with medical supervision, requiring the parent to work with the child&rsquo;s primary care provider); and</li>
              <li>be willing to give blood samples at two time points: baseline and week 8, with an optional week 16 blood draw</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>having a neurological disorder involving brain or other central function (e.g., history of or suspected intellectual disability, autism spectrum disorder, epilepsy, narcolepsy) or other major psychiatric condition requiring hospitalization (e.g. significant mood disorder, active suicidal ideation, or psychosis)</li>
              <li>having any serious medical condition, including inflammatory bowel disease, history of cancer, kidney or liver disease, hyperthyroidism, diabetes</li>
              <li>having a known allergy to any ingredient in the intervention</li>
              <li>having any known abnormality of mineral metabolism (e.g., Wilson&rsquo;s disease, hemochromatosis)</li>
              <li>currently taking any other medication with primarily central nervous system activity, including stimulants, or having taken any within two weeks prior to enrollment</li>
              <li>having severe anxiety preventing separation from parent to answer study questionnaires</li>
              <li>having any disability that would interfere with participant answering questions verbally</li>
              <li>not able to communicate in English</li>
              <li>being pregnant or sexually active at baseline (specific to girls who started menstruating).</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p>ADHD as assessed by the CASI-5, symptom of irritability or anger from the ODD or DMDD subscale questions</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Rucklidge 2018</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>Between 7 and 12 years</li>
              <li>Considered reliable and compliant with the protocol (including the ingestion of as many as 12 capsules/day with food)</li>
              <li>Meet criteria for ADHD as assessed by the K-SADS, and the Conners Rating Scales (T score greater than 65 on both parent and teacher form for any of the ADHD DSM-IV subscales).A subset (n=20) of children (males with Combined ADHD) will be asked to participate in an 1H-MRS pilot study in order to begin documenting the impact that nutrition has on the brains of ADHD children. Those participants must be compatible with the imaging scanner (i.e. no braces, no history of claustrophobia).</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>Neurological disorder involving brain or other central function (e.g., intellectual disability as assessed by the Wechsler Intelligence Scale for Children, autism spectrum disorder, epilepsy, MS, narcolepsy) or other major psychiatric condition requiring hospitalization (e.g. significant mood disorder or psychosis)</li>
              <li>Any serious medical condition</li>
              <li>Any patient known to be allergic to the ingredients of the intervention</li>
              <li>Any known abnormality of mineral metabolism (e.g., Wilson&rsquo;s disease, haemochromatosis)</li>
              <li>Any other medication with primarily central nervous system activity, including stimulants. Participants must have been off of these medications for a minimum of four weeks prior to the trial.</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p>"ADHD as assessed by the K-SADS, and the Conners Rating Scales (T score greater than 65 on both parent and teacher form for any of the ADHD DSM-IV subscales)"</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Deli 2017</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>normal BMI, normal iron status, absence of lower-limb musculoskeletal injury, no drug/supplement consumption, absence of any allergy in iron salts, participants did not undertake any scheduled eccentric exercise or other activities with large eccentric component for at least 6 mo before the study, and they did not spend more than 3 h weekly on sport activities, written informed consent was provided by all adults and children&rsquo;s parents/guardians after they were informed about all risks, discomforts, and benefits involved in the study</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Nair 2017</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;without anaemia, i.e. Hb 11 or more and excluded babies who are preterm less than 1500 g birth weight, c/c systemic illness and haemopoietic disorders&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;anaemia, i.e. Hb 11 or more"; &ldquo;Anaemia in infants is defined as haemoglobin, haematocrit and RBC count less than 2SD for mean age, sex and race. Haemoglobin &lt;11, haematocrit &lt;33 is considered as anaemia in infants and toddlers. Iron deficiency anaemia is considered when MCV &lt;70 fl, MCH &lt;23 pg, MCHC &lt;30 g% for 6-24 months4 and serum ferritin &le;12. Iron deficiency anaemia in children can be classified as mild - Hb 10 - 10.9 g/dL, moderate - Hb 7 - 9.9 g/dL, severe &ndash; Hb &lt; 7 g/dL. Haemoglobin concentration is most often used for anaemia screening in children from 4 months to 1 year.&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Lozoff 2016</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants 6 wk to 9 mo of age born to women with uncomplicated singleton pregnancies at 16 wk of gestation</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>maternal age &lt; 18 y, not living in Sanhe, not mentally competent, chronic health problem, haemoglobin &lt; 100 g/L, having taken medicinal iron for any duration, cord-blood serum ferritin &lt; 35 mg/L</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia at 9 mo: haemoglobin &lt; 110 g/L</p>
            <p>ID: &ge; 2 abnormal iron measures by cutoff:mean corpuscular volume &lt;74 fL, zinc protoporphyrin/haeme &gt; 69 &micro;mol haeme/mol, serum ferritin &lt; 12 &micro;g/L] or body iron (BI) &lt; 0 mg/kg, calculated from serum ferritin and soluble transferrin receptor</p>
            <p>IDA: anaemia + ID</p>
            <p>foetal-neonatal ID: cord serum ferritin &lt; 75 &micro;g/L or ZnPP/haeme &gt; 118 &micro;mol haeme/mol</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Hamza 2014</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>Age 6-15 years old, both genders were eligible, did not seek to balance the number between sex, completed the compulsory vaccination schedule of Egypt.</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>Children with coexisting chronic disease (such as renal, hepatic failure, IDDM, endocrine diseases, bronchial asthma, chronic diarrhea, and any immunological disorders), suspected immunodeficiency by presence of some of the warning symptoms or signs, severe iron deficiency anemia (Hb &lt;9 g/dl).</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p> 
            </p>
          </td>
        </tr>
        <tr>
          <td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>Singh 2014<br>  
              <br>  
              <br>  
              <br>  
              <br>  
              <br>  
              <br>  
            </p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria<br>  
            </p>
          </td><td style="vertical-align: top;">
            <p>adolescent girls 16 to 19 y of age with moderate anaemia from College of Home Science, SKRAU, Bikaner<br>  
              <br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash; </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>moderate anaemia: haemoglobin 8.0 to 10.9 g/dL </p>
          </td>
        </tr>
        <tr>
          <td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>Chen 2013<br>  
              <br>  
            </p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria<br>  
            </p>
          </td><td style="vertical-align: top;">
            <p>children 3 to 6 y of age,from about eight kindergartens in the study region (Huayuan Town, Pixian County ofChengdu City, Sichuan Province, western China), apparently good health, haemoglobin &gt; 60 g/L, CRP &lt; 10 mg/L, parental or guardian&rsquo;s approval for participating in all aspects of the study, parental/guardian&rsquo;s agreement to avoid additional use of vitamin A and iron supplements during the investigation </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>"Children with evidence of recent acute or chronic illnesses and/or haemoglobin &lt; 60 g/L were excluded and were referred to a local medical center for treatment." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>morbidity episode: defined as an event of morbidity symptoms with 3 illness-free days between events<br>  diarrhoea: passage of loose or liquid stools and a high stool frequency (&gt; 3 stools/day) </p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Nogueira Arcanjo 2013</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;All infants from the three daycare centers were invited to participate in the study&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;exclusion criterion used was infants already receiving iron supplements. Intervention started and ended for all participants on the same day.</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Zhang 2013</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>All fourth grade students (both male and female students ages 9-12 years) in 66 randomly selected rural primary schools in eight of the poorest counties in China's Shaanxi province, in China's northwest region.</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>Students found to be extremely anaemic (sent directly to a doctor for treatment) or low body weight</li>
              <li>Students identified as having thalassaemia</li>
              <li>Students not meeting inclusion criteria</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p>Anemia (using the 120 g/L cut off), anxiety (MHT test).</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Gokcay 2012</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants at 6 mo of age, gestational age &ge;37 wk, birthweight &gt; 2500 g, singleton birth, no history of gestational diabetes, an uneventful perinatal history, no chronic disease, no known genetic disease or major congenital malformation, no history of hospitalisation &gt; 7 d during the neonatal period, no iron supplementation before 6 mo of age, exclusive breastfeeding for the first 4 mo of life</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>ID: ferritin &lt; 10 &micro;g/L</p>
            <p>anaemia: haemoglobin &lt; 10.3 g/dL</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Radjen 2011</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>having regular menstrual cycle; healthy</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>latent iron deficiency: ferritin &lt;12 &micro;g/L, transferrin saturation &lt; 16%, haemoglobin &gt; 120 g/L;</p>
            <p>
              <br> iron deficiency anaemia: ferritin &lt; 12 &micro;g/L, transferrin saturation &lt; 16%, haemoglobin &lt; 120 g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Kamble 2011</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>adolescents with anaemia who were residential scholar of the school, haemoglobin &lt; 12 g/dL</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>day scholar of the school, haemoglobin &gt; 12 g/dL, unwilling to provide consent</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 12 g/dL</p>
            <p>mild anaemia: 10 to 11.9 g/dL</p>
            <p>moderate anaemia: 7 to 10 g/dL</p>
            <p>severe anaemia: haemoglobin &lt; 7 g/dL</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Moafi 2011</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>Female students aged 18-26 with normal hemoglobin, or normal hemoglobin but low ferritin (&lt;20 ng/dL)</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>Students with hemoglobin &lt;12 g/dL</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>Hb &lt;12 g/dL, feritin &lt;20 ng/dL</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Hacihamdioglu 2013</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>healthy infants 4 mo of age, exclusively fed on breast milk until 6 mo of age, good health based on prenatal, natal, and postnatal histories and physical examination,no previous iron supplementation, no ID or iron deficiency anaemia according to complete blood cell count and ferritin measurements</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>ID: serum ferritin &le; 12 &micro;g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Chang 2010</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>Children 6-18 months old</li>
              <li>Permanent residents of the selected villages</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>Severe malnutrition requiring hospitalization (defined as weight for height &lt;-3 SD Z-score)</li>
              <li>Severe anemia requiring treatment (hemoglobin &lt; 70 g/L)</li>
              <li>Chronic illness that would impair feeding ability</li>
              <li>Likely to move in next 6 months.</li>
              <li>Fever greater than 38.5</li>
              <li>Regular iron supplementation</li>
              <li>Currently participating, or participation within 30 days prior to study entry, in an investigational drug study</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria </p>
          </td><td style="vertical-align: top;">
            <p>WHZ &lt;-3 SD. anemia (Hb &lt;70 g/L)</p>
          </td>
        </tr>
        <tr>
          <td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>Ziegler 2009b<br>  
              <br>  
              <br>  
              <br>  
            </p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria<br>  
            </p>
          </td><td style="vertical-align: top;">
            <p>"term infants of both sexes with a birthweight &gt;2500 g and who were considered healthy by their physicians and the investigators. The infants were born between August 2001 and July 2003. At recruitment at 1 mo of age, the infants were exclusively breastfed (vitamin-mineral drops were permitted)"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria<br>  
            </p>
          </td><td style="vertical-align: top;">
            <p>"1 infant was excluded because he (subject 10117) developed ID at 2 mo of age and was treated with iron, and 10 infants were excluded at 4 mo because they received &gt;200 mL formula/d"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria<br>  
            </p>
          </td><td style="vertical-align: top;">
            <p>predominantly breastfed: receiving &lt;200 mL supplemental formula/d, equivalent to &asymp; 20% of estimated energy intake"<br> mild ID (depleted iron stores): plasma ferritin &lt; 10 &micro;g/L</p>
            <p>anaemia: haemoglobin &lt; 105 g/L before 9 mo of age, &lt; 100 g/L at 9 mo of age and older [<a href="#422017777074348892">5</a>]</p>
            <p>IDA: anaemia in the presence of plasma ferritin &lt; 10 g/L.</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Ziegler 2009a</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>term- born infants born at 1  mo of age, birthweight &gt; 2500 g, exclusively breastfed at 1 mo of age and whose mothers intended to breast feed to at least 5.5 mo of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>to remain in the study, at 4 mo infants had to be predominantly breastfed (defined as 200 mL/d of formula) and at 5.5 mo had to be receiving at least some breast milk</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>iron deficiency: plasma ferritin &lt; 10 &micro;g/L</p>
            <p>anaemia &lt; 9 mo of age: haemoglobin &lt; 105 g/L</p>
            <p>anaemia at &ge; 9 mo of age: haemoglobin &lt; 100 g/L</p>
          </td>
        </tr>
        <tr>
          <td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>Hettiarachchi 2008</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>adolescents 12 to 16 y of age with haemoglobin &ge; 80 g/L</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children suffering from acute or chronic diseases, inflammatory conditions, with a history of any drug consumption other than paracetamol or antihistamines for minor ailments, currently consuming nutrient supplements or having donated blood or received a blood transfusion within the last 4 mo</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &le; 120.0 g/L</p>
          </td>
        </tr>
        <tr>
          <td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>Engstrom 2008</p>
            <p> 
            </p>
            <p> 
            </p>
            <p>
              <br>  
            </p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children 6 mo &plusmn; 29 d of age at the time of recruitment, absence of iron salt supplementation in the month preceding recruitment, negative for sickle-cell anaemia during routine neonatal screening, control group only: absence of iron salt supplementation between 5 to 12 mo of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 110.0 g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Fallahi 2007</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;All children in fifth grade...were considered as potential participants&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;Subjects with renal failure, talassemia, tuberculosis, par</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Fahmida 2007</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>"aged 3-6 months old at enrollment, predominantly breast-fed, and free from apparent congenital abnormalities"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>Analysis of growth: infants with length-for-age z-score &lt; -5 or &gt; 3</li>
              <li>Analysis of haematological outcomes: infants with haemoglobin &lt; 6g/dL</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>blood sample obtained from heel-prick and collected using filter paper methods</p>
            <ul>
              <li>anaemia: haemoglobin &lt; 10 g/dL</li>
              <li>ID: nr</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>Wasantwisut 2006</p>
            <p> 
            </p>
            <p> 
            </p>
            <p>
              <br>  
            </p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>predominantly breast fed infants 4 to 6 mo of age, free from apparent congenital abnormalities, parental consent</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>haemoglobin &lt; 80 g/L, chronic illnesses, bottle fed</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>anaemia at 4 to 6 mo: Hb &lt; 105 g/L</li>
              <li>anaemia at 10 to 12 mo: haemoglobin &lt; 100 g/L</li>
              <li>ID at 4 to 6 mo: serum ferritin &lt; 12 &micro;g/L</li>
              <li>ID at 10 to 12 mo: serum ferritin &lt; 20 &micro;g/L</li>
              <li>ID anaemia at 4 to 6 mo: haemoglobin &lt; 105 g/L and serum ferritin &lt; 12 &micro;g/L</li>
              <li>ID anaemia at 10 to 12 mo: haemoglobin &lt; 100 g/L and serum ferritin &lt; 20 &micro;g/L</li>
              <li>low serum zinc: &lt; 10.7 &micro;mol/L</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Eftekhari 2006</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;(a) the absence of any systemic disease, including anaemia (haemoglobin &lt;12 mg/dl); (b) serum albumin within the normal range: 3.5&ndash;5.5 g/dl; (c) urinary iodine &gt;100 mg/l; (d) body mass index 419 kg/m 2 ; (e) age within the range of 14&ndash;18 years&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;Serum albumin was used as an indicator of malnutrition. Plasma selenium was measured because a low level of this trace element may have a negative effect on iodine metabolism, and urinary iodine was measured as an indicator of iodine deficiency.&rdquo;</p>
          </td>
        </tr>
      </table>
    </div>
    <div>
      <table>
        <tr>
          <td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>Bobonis 2006</p>
            <p> 
              <br>  
            </p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children 2 to 6 y of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 11 g/dL</p>
            <p>severe anaemia: haemoglobin &lt; 7 g/dL</p>
            <p>moderate anaemia: haemoglobin 7 to 10 g/dL</p>
          </td>
        </tr>
        <tr>
          <td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>Berger 2006</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>singleton breast-fed infants, between 4 and 7 mo of age, written informed consent</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>chronic or acute illness, severe malnutrition or congenital abnormality</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 110 g/L</p>
            <p>ID anaemia: simultaneous low serum ferritin and anaemia</p>
            <p>low iron stores: serum ferritin &lt; 12 mg/L; low serum zinc: serum zinc &lt; 9.9 mmol/L</p>
            <p>stunting: HAZ &lt; -2 z-scores</p>
            <p>wasting: WHZ &lt; -2 z-scores</p>
            <p>underweight: HAZ &lt; -2 z-scores</p>
          </td>
        </tr>
        <tr>
          <td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>Rosado 2006</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children 6 to 7 y of age, signed parental consent</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>haemoglobin &lt; 9 g/dL, blood lead concentration &gt; 45 mg/dL</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 12.4 g/dL (cutoff value adjusted for the altitude of 2300 m for this age group)</p>
            <p>ID: serum ferritin &lt; 12 &micro;g/L</p>
            <p>depleted iron stores: serum ferritin &lt; 15 &micro;g/L</p>
            <p>zinc deficiency: serum zinc &lt; 65 &micro;g/dL</p>
          </td>
        </tr>
        <tr>
          <td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>Untoro 2005</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants 6 to 12 mo of age who were enrolled in the Indonesia IRIS study with baseline C-reactive protein and alpha-1 acid glycoprotein data available, permanent residents of an area where the prevalence of anaemia and vitamin A deficiency were 30%</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>birth &lt; 37 wk of gestation, birthweight &lt; 2500 g, severe wasting, haemoglobin &lt; 80 g/L, fever on the day of blood sampling, failure to obtain informed consent form</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>inflammation: CRP &gt; 5 mg/L or AGP (alpha-1 acid glycoprotein) &gt; 1 g/L at baseline</p>
            <p>ID: ferritin &lt; 12 &micro;g/L</p>
            <p>hypozincaemia: plasma zinc concentration &lt; 10.7 &micro;mol/L</p>
            <p>anaemia: haemoglobin &lt; 110 g/L</p>
            <p>vitamin A deficiency: serum retinol &lt; 0.7 &micro;mol/L</p>
            <p>severe wasting: &lt; -3 Z-scores</p>
            <p>fever: body temperature &gt; 39&deg;C</p>
          </td>
        </tr>
        <tr>
          <td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>L&oacute;pez de Roma&ntilde;a 2005</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants 6 to 12 mo of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>no signed informed consent, premature birth of the child, birthweight &lt; 2500 g, congenital defects, chronic infection, severe wasting (weight-for-height Z-score &lt; -3 SD), fever (&gt; 39&deg; C), severe anaemia (haemoglobin &lt; 80 g/L)</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>cutoff values for deficiency: 110 g/L for haemoglobin, 12 g/L for ferritin, 10.7 mol/L for zinc, 0.7 mol/L for retinol, EGRAC 1.4 for riboflavin</p>
            <p>stunting and wasting: &lt; -2 Z-scores for height-for-age and weight-for-height, respectively, compared with international reference values</p>
            <p>underweight and overweight: &lt; -2 Z scores of weight for age and &gt; 2 Z scores of weight for height, respectively</p>
            <p>diarrhoea: &ge; 4 watery stool</p>
            <p>upper respiratory infection: presence of cough, runny nose, earache, or sore throat the previous day</p>
            <p>fever: presence or absence</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Hop 2005</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;Infants aged from 6 to 12 mo were identified by a house-to-house search, and the mothers and/or caretakers were invited to participate in the study&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;Additional exclusion criteria were severe wasting (weight-</p>
            <p>for-height Z-score 3 Z), fever (39&deg;C), premature birth (37 wk) or low birth weight (2500 g), and severe anemia [hemoglobin (Hb) 80 g/L]&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>Anemia: &lt;110 g/L; Low ferritin: &lt;12ug/L; Low retinol: &lt;0.70umol/L; Low zinc: &lt;10.7umol/L</p>
          </td>
        </tr>
        <tr>
          <td colspan="1" rowspan="3" style="vertical-align: top;">
            <p>Yurdak&ouml;k 2004</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants 4 mo of age, gestational age &gt; 37 wk, birthweight &gt; 2500 g, singleton birth, no congenital malformation, no perinatal disease, breast milk as the only source of food on admission, no history of iron supplementation or therapy, no known haematologic disorder of mother&ndash;infant pairs, mother intended to breastfeed exclusively until 6 mo of age and to continue breastfeeding with introduction of complementary foods no earlier than 7 mo of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants or mothers with ID or ID anaemia on admission</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>4 to 5 mo of age</p>
            <p>ID: serum ferritin &lt; 12 &micro;g/L</p>
            <p>IDA: haemoglobin &lt; 9.5 g/dL, in combination with MCV &lt; 74 fl, serum ferritin &lt;12 &micro;g/L, serum iron: &lt; 18 &micro;g/dL, and transferrin saturation &lt; 10%</p>
            <p>6 to 7 mo of age</p>
            <p>ID: serum ferritin &lt; 10 &micro;g/L</p>
            <p>IDA: haemoglobin &lt; 10.5 g/dL, in combination with MCV &lt; 70 fl, serum ferritin &lt;10 &micro;g/L, serum iron: &lt; 30 &micro;g/dL and transferrin saturation &lt; 12%</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Tsalis 2004</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>healthy adolescent swimmers 12 to 17 y of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia, ID, chronic or acute illnesses</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>absence of anaemia: haemoglobin &gt; 12 g/dL</p>
            <p>absence of ID: ferritin &gt; 7 ng/mL</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Rosales 2004</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>school-children from low-income families aged 8 to 11 y with "usual good health and the absence of chronic disease"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 121 g/L (in 8 to 12 y old children at elevated altitude approximately 4000 feet above sea level)</p>
            <p>ID: ferritin &lt; 20 &micro;g/L</p>
            <p>hypozincaemia: plasma zinc concentrations &lt; 10.7 &micro;mol/L</p>
            <p>inflammation status based on one or more acute phase protein concentrations above their respective cutoffs: C-reactive protien &ge; 10 mg/L, AGP &ge; 1.0 g/L , alpha-1 antichymotrypsin &ge; 0.6 g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Nagpal 2004</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants 4 to 6 mo of age, full-term gestation between 37 to 41 wk, birthweight &gt; 2500 g</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>twins, congenital malformation, history of blood transfusion, blood sampling (&gt; 10 mL) prior to recruitment, infants already receiving iron supplementation, adverse neonatal events requiring admission to the special newborn care nursery, presence of a significant current morbidity</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>ID: haemoglobin &lt; 9.5 g/dL, MCV &lt; 74 fl, ferritin &lt; 12 ng/mL</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Metallinos-Katsaras 2004</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children 3 to 4 y of age, birth weight &ge; 2500 g, currently healthy, benign past medical history, IQ (based on the Griffith&rsquo;s Mental Development Scales) &ge; 1 standard deviation below the age-adjusted mean, blood lead &le; 200 ppb and height, weight and head circumference for age &ge;10th percentile (NCHS 1976 )</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>iron-deficiency anaemia: baseline haemoglobin &lt; 112g/L, transferrin saturation &lt; 16% and ferritin &lt; 12 &micro;g/L or haemoglobin rise &gt; 10 g/L with iron supplementation</p>
            <p>good iron status: baseline haemoglobin &gt; 120 g/L and either transferrin saturation &gt; 20% or serum ferritin &gt; 12 &micro;g/L.</p>
            <p>Non-response: a change in haemoglobin of &lt; 7.5 g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Wieringa 2003</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants 4 mo of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 110 g/L</p>
            <p>IDA: anaemia and plasma ferritin concentration &lt; 12 &micro;g/L</p>
            <p>vitamin A deficiency: plasma retinol concentration &lt; 0.70 &micro;mol/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Majumdar 2003</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children 6 to 24 mo of age, birthweight &gt; 2500 g, products of singleton pregnancy, weight, length and head circumference within 2 standard deviations of the National Center for Health Statistics reference standards, adequate dietary protein and calorie intake, no signs of vitamin or micronutrient deficiencies</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>major congenital anomaly or prenatal complications, hospital admission or iron supplementation during the mo before enrolment, chronic illness, anaemia other than ID, recent blood transfusion.</p>
            <p>Children developing chronic diarrhoea, fever lasting &gt; 7 d or those requiring any hospital admission during the course of the study were dropped from follow-up.</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>iron repletion: haemoglobin &gt; 110 g/L, serum ferritin &gt; 12 μg/L, and serum transferrin saturation &gt; 10 %</p>
            <p>ID: haemoglobin 50 to 110 g/L, serum ferritin &lt; 12 μg/L, and serum transferrin saturation &lt; 10 %</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Lind 2003</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>healthy, singleton infants &le; 6 mo of age from the surveillance area whose mothers had been monitored during pregnancy and birth</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>metabolic or neurologic disorders, physical handicaps affecting development, feeding, or activity, severe or protracted illness and infants with haemoglobin concentrations &lt; 90 g/L on assessment of eligibility were excluded after examination by the study physician, infants in whom initial blood sampling failed and haemoglobin could not be assessed</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 110 g/L</p>
            <p>low serum ferritin: &lt; 12 g/L</p>
            <p>ID anaemia: low haemoglobin and SF)</p>
            <p>low serum zinc: &lt; 10.7 mol/L</p>
            <p>stunting: length for age &lt; 2 SDs of WHO growth reference values</p>
            <p>vomiting: defined as vomiting reported as a side effect during supplementation at the follow-up interview</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Friel 2003</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>breast-fed infants, maternal intent to breast-feed exclusively (with &le; 1 supplemental</p>
            <p>feed/day for &ge; 4 mo)</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>gestational age &lt; 37 wk, birth weight &lt; 2.5 kg, multiple pregnancy, major illness requiring intensive care admission, major congenital anomaly</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Agarwal 2003</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>females</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>exclusion from analysis: haemoglobin &lt; 7.0 g/dL</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 120 g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Sungthong 2002</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>parental informed consent</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children with severe IDA, severe malnutrition, chronic illness such as obvious thalassaemia or haemolytic disease, high iron storage, physical handicaps, no baseline laboratory assessment</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>ID anaemia: haemoglobin &lt; 80 g/L and SF &lt; 20 &micro;g/L</p>
            <p>anaemia for children &lt; 12 y: haemoglobin &le; 115 g/L</p>
            <p>anaemia for children &ge; 12 y: haemoglobin &le; 120 g/L</p>
            <p>high iron storage: serum ferritin &ge; 100 &micro;g/L</p>
            <p>severe malnutrition: weight for height &le; 3rd percentile of the Thai reference</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Shah 2002</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>females 11 to 18 y of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>chronic illnesses (e.g., asthma, rheumatic heart disease), any long-term allopathic or indigenous drug treatments, severe illness requiring hospitalisation within the past 2 wk</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haematocrit &lt; than 36 %</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Ermis 2002</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants at 5 mo of age, no gestational problem (hypertension, pre-eclampsia, ablatio placenta, infection), no congenital anomalies, no neonatal complications, no emergency caesarean section, no jaundice requiring phototherapy, no prior hospitalisations, no chronic illness, no iron therapy, no formula feeding and having exclusive breastfeeding, birthweight &gt; 3.0 kg, gestational age &gt; 37 week</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants who had an infection during iron supplementation</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>ID: haemoglobin in normal ranges, but MCV &lt; 74 fl and serum ferritin &lt; 12 ng/mL</p>
            <p>ID anaemia at 5 mo: haemoglobin &lt; 9.5 g/dL, MCV &lt; 74 fl, and serum ferritin &lt; 12 ng/mL</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Lambert 2002</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;870 female students attending a high school in Auckland, New Zealand&rdquo;; &ldquo;iron-deficient without being anaemic</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;iron-deficient without being anaemic (serum ferritin &lt;12 mg/l, haemoglobin &gt;120 g/l)&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Domell&ouml;f 2001a</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants at 4 mo of age, gestational age &ge; 37 wk, birth weight &gt; 2500 g, no chronic illness, maternal age &ge; 16 y, infant exclusively breast-fed at 4 mo (and &le; 90 mL/d of formula during any period since birth), mother intended to exclusively breast-feed until 6 mo (&le;1 tablespoon per day of foods or fluids other than breast milk, and no iron-fortified foods) and to continue breast-feeding to at least 9 mo</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 110 g/L, ID: 2 of 3 abnormal iron status indices: ferritin &lt; 12 μg/L, MCV &lt; 70 fL, zinc protoporphyrin &gt; 80 μmol/mol heme</p>
            <p>IDA: anaemia in combination with ID</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Dijkhuizen 2001</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants at 4 &plusmn; 0.5 mo of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>chronic or severe illness, severe clinical malnutrition or congenital anomalies</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 110 g/L, moderate and severe anaemia: haemoglobin &lt; 90 g/L</p>
            <p>IDA: anaemia combined with plasma ferritin concentration &lt; 12 &micro;g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Geltman 2001</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;Subjects included healthy, full-term infants enrolled at their 6-month well-child visit&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;Infants with premature birth, hematologic or gastrointestinal abnormalities, and previous supplement use were excluded from the study.&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;Anemia was defined as a Hct &lt;33% or Hb &lt;11 g/dL. Iron deficiency without anemia was defined as ZP &gt;35 mcg/dL and Pb &lt;10 mcg/dL, or RDW &gt;14.5 with normal Hb and Hct.&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Zavaleta 2000</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>adolescent school girls<b> </b>12 to 18 y of age who have been living in the community for at least 6 mo before the study, healthy, nuliparous, menstruating regularly in the last 3 mo, no intake of any multivitamin-mineral supplement in the last 6 mo<br> haemoglobin &gt; 80 g/L</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 120 g/L</p>
            <p>ID: serum ferritin &lt; 12 &micro;g/L, free erythrocyte protoporphyrin &gt; 80 &micro;g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Lanerolle 2000</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>girls 13 to 19 y of age attending schools in Colombo and who had attained menarche, no history of any major illness</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 120 g/L, transferrin saturation &lt; 16%</p>
            <p>depleted iron stores: ferritin &lt; 12 μg/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Kianfar 2000</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemic and non-anaemic female students from four high school classes of grades 1 to 3 in the cities of Rasht and Zahedan</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>thalassaemia</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin adjusted for altitude adding a correction factor of 4 % for each 1000 meters above sea level</p>
            <p>anaemia in Rasht: haemoglobin &lt; 12 g/dL</p>
            <p>anaemia in Zahedan (altitude of 1370 meters from sea level) haemoglobin &lt; 12.7 g/dL</p>
            <p>thalassaemia: Mentzer formula MCV/RBC &lt; 13</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Arvas 2000</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>full-term infants born born at the Department of Obstetrics of Cerahpasa Medical Faculty of Istanbul University, all were exclusively breastfed for four mo and &ge; 2500 g at birth with no perinatal or postnatal problem, none of the mothers had hypertension, chronic diseases, preeclampsia, or ablatio placentae</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>ID and/or anaemia at 4 mo of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>baseline: IDA: haemoglobin &lt; 9.5 g/dL, MCV &lt; 74 fl, serum ferritin &lt; 12 ng/mL</p>
            <p>ID: haemoglobin &gt; 9.5 g/dL, serum ferritin &lt;12 ng/mL</p>
            <p>4 to 6 mo of age: IDA: haemoglobin &lt; 11 g/dL, MCV &lt; 70 fl and SF &lt;12 ng/mL</p>
            <p>ID: haemoglobin &gt; 11 g/dL and serum ferritin &lt; 12 ng/mL</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Yal&ccedil;in 2000</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;(i) infants had to have a gestational age between 38 and 42 weeks; (ii) the birthweight had to be &gt;2500 g; (iii) it had to have been a singleton pregnancy; (iv) no pathologic jaundice during the newborn period; (v) no major congenital anomaly; (vi) no illness in the preceding 1 month before enrollment into the study; (vii) head circumference, height and weight within ~2SD of mean values for chronological age according to National Center for Health Statistics growth charts; 16 (viii) no central nervous system disorders; and (ix) no history of iron supplementation or therapy"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Lynn 1998</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>Raven's standard progressive matrices (non-verbal reasoning test)</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Kanani 1998</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>unmarried girls 10 to 18 y of age, residing in one of three low-income communities in Vadodara</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Faqih 1998</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>full-term infants 3 mo of age, appropriate-for-gestational age, willingness of mothers to continue exclusive breastfeeding for at least 4 mo postpartum, complete informed consent to the study protocol</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>haemoglobin &lt; 10.5 g/dL</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>3 mo of age: nutritional anaemia: haemoglobin &lt; 9.5</p>
            <p>ID: haemoglobin &lt; 9.5 g/dL, MCV &lt; 70 fL, and plasma ferritin &lt; 12 ng/mL</p>
            <p>6 mo of age: nutritional anaemia: haemoglobin &lt; I0.5 g/dL</p>
            <p>ID: haemoglobin &lt; 10.5 g/dL, MCV &lt; 70 fL, and plasma ferritin &lt; 12 ng/mL</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Buzina-Suboticanec 1998</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children attending the third grade of an elementary school near Zagreb between 8.7 and 9.6 y of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Rosado 1997</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>age 18 to 36 mo</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>ID: plasma ferritin &lt; 12 &micro;g/L</p>
            <p>stunting: height-for-age Z score (HAZ) &lt; -2.0</p>
            <p>respiratory disease: any symptom such as runny nose, common cold, sore throat, cough</p>
            <p>diarrhoea: maternal report of frequent, loose stools, fever: maternal report</p>
            <p>vitamin A deficiency: &lt; 0.70 mmol/L retinol</p>
            <p>zinc deficiency: &lt;10.7 mmol/L zinc</p>
            <p>anaemia: haemoglobin (increased by 0.5 g/L for the altitude of 2300 m) &lt; 115 g/L and haematocrit (increased by 2% for altitude) &lt; 35%</p>
            <p>MCV: low: &lt; 73 fL, elevated: &gt; 87 fL</p>
            <p>MCH: low: &lt; 27 pg, elevated: &lt; 32 pg</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Mitra 1997</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children 2 to 48 mo of age</p>
            <ul>
              <li>Morbidity: infants and young children aged 2 to 48 mo of either sex</li>
              <li>Anthropometry: infants and young children aged 6 to 71 mo of age</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children who were critically ill or who had evidence of congenital malformation or metabolic disorders, clinical signs of anaemia</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p> &mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Lee 1997</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;Thirty-five female adolescent students of a middle school in a rural area participated in this study. They ranged in age from 12 &ndash; 15 years and had experienced menstruation for more than 6 months. All of them were apparently healthy&rdquo;; &ldquo;The subjects with relatively poor iron status were selected on the basis of preliminary hemoglobin concentration(Hb) and hematocrit(Hct) screening.&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;individuals on any form of vitamin or mineral supplementation were excluded from the study.&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Berger 1997</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>haemoglobin concentration &le; 144 g/L</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
      </table>
    </div>
    <div>
      <table>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Northrop-Clewes 1996</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>breastfed infants &lt; 2 y of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants receiving iron-fortified formulas or iron-containing mediation, family history or clinical features of thalassaemia (such as broad faces with high cheek bones, frontal bossing, and a mild to moderate enlargement of the spleen, severely malnourished (based on weight-for age z-scores), clinical symptoms of acute or chronic infection</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Lozoff 1996</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>non-anaemic and 32 anaemic children 12 to 23 mo of age, haemoglobin &le; 105 g/L or finger-stick haemoglobin &ge; 120 g/L, birthweight &ge; 2.5 kg, uncomplicated singleton birth, free of acute or chronic medical problems, visited Hospital Nacional de Ni&ntilde;os for a physical examination</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>moderate ID anaemia: haemoglobin &le; 100 g/L and two of three iron measures indicating ID: serum ferritin level &le; 12 &micro;g/L, erythrocyte protoporphyrin concentration &gt; 100 &micro;g/dL packed erythrocytes, or transferrin saturation &le; 10%</p>
            <p>absence of anaemia: haemoglobin &ge; 12.5 g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Bruner 1996</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>girls with non-anaemic ID</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 11.5 g/dL for African American girls or &lt; 12.0 g/dL for white girls</p>
            <p>non-anaemic ID: &lt; 12.0 &micro;g/L with a normal haemoglobin concentration</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Thibault 1993</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children 6 mo to 3 y of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>chronic disease, presence of an infection within 2 wk prior screening, iron or folic acid supplement intake within the 3 mo preceding the study. Children presenting a haemoglobin &lt; 90 g/L were secondarily excluded</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: according to WHO criteria</p>
            <p>ID: combination of at least two abnormal values for the three following indicators: serum ferritin level &lt; 12 &micro;g/L, transferrin saturation &lt; 12%, and erythrocyte protoporphyrin concentration &gt; 3 &micro;g/g haemoglobin</p>
            <p>depletion of iron stores: low serum ferritin level: serum ferritin &le; 12 &micro;g/L without other abnormalities in iron parameters</p>
            <p>inflammatory process: C-reactive protein concentration &gt; 12 mg/L and/or the orosomucoid level &gt; 1.4 g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Idjradinata 1993</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants 12 to 18 mo of age, birthweight &gt; 2500 g, singleton pregnancy, no major congenital anomalies or perinatal complications, no jaundice treated with phototherapy, no hospital admission or supplementation with micronutrients during the 6 mo before enrolment, no chronic illness or folic acid deficiency, haemoglobin &ge; 80 g/L, no signs of abnormal haemoglobin or thalassaemia, weight, length, and head circumference &ge; 2 SD of National Center for Health Statistics reference standards</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>haemoglobin &gt; 105 and haemoglobin &lt; 120 g/L</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>iron sufficiency: haemoglobin &gt; 120 g/L, transferrin saturation &gt; 10%, serum ferritin &gt; 12 &micro;g/L</p>
            <p>IDA: haemoglobin &le; 105 g/L, transferrin saturation &le; 10%, serum ferritin &le; 12 &micro;g/L<br> non-anaemic ID: haemoglobin &ge; 120 g/L, transferrin saturation &le; 10%, and serum ferritin &le; 12 &micro;g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Boivin 1993</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children in the 1<sup>st</sup> year of primary school, physical examination, health and cognitive assessment</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>positive for trophozoites</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 12 g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Bhatia 1993</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children 3 to 5 y of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>mild anaemia</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>mild anaemia: haemoglobin 10.1 to 10.9 g/dL<br> moderate anaemia: haemoglobin 7 to 10 g/dL</p>
            <p>no anaemia: haemoglobin &ge; 11 g/dL</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Paracha 1993</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;those having the symptoms of illnesses and nutritional deficiencies other than iron deficiency were excluded from the study.&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;iron deficiency anemia was defined as serum ferritin: &le; 12 ng/ml and hemoglobin &lt; 12 g/dl or hematocrit &le; 35%&rdquo;; &ldquo;The sensitivity of the diagnosing criteria was assessed by selecting a cut-off point of 1 g/dl rise in hemoglobin value of the anemic group following iron supplementation.&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Hathirat 1992</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children 108 to 144 mo of age, absence of AE Bart's or haemoglobin H disease, absence of abnormal haemoglobin EE</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>exclusion from data analysis: absence of haemoglobin value at either/both measuring time points, &gt; 1 missing value of transferrin saturation, serum ferritin or free erythrocyte protoporphyrin, no administration of a daily dose of 2 mg elemental Fe/kg initial weight</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 120 g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Irigoyen 1991</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>6-mo-old healthy, low-income, minority infants, venous haemoglobin between 9 to 11.5 g/dL</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>failure to thrive and human immunodeficiency virus seropositivity, recent Haemophilus Influenzae type b meningitis, fed low-iron formulas, breast-fed exclusively, primary physician refusal, prematurity (&lt; 32 wk), milk allergy, parental refusal to participate</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>normal haemoglobin: haemoglobin 11 to 11.5 g/dL</p>
            <p>low haemoglobin: haemoglobin &lt; 11 g/dL</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Walter 1989</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants 12 mo of age, birthweight &gt; 2500 g, no neonatal complication, no chronic or congenital disorders, adequate growth and development</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 10.5 g/dL and two or more abnormal measurements</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Soewondo 1989</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>female household head working on a plantation, presence of a husband and at least one pre-school child in the household, the family lives inside a plantation</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>iron depletion: haemoglobin &ge; 110g/L + two of three criteria: ferritin &lt; 12 &micro;g/L, transferrin saturation &lt; 16 %, free erythrocyte protoporphyrin &gt; 1.77 &micro;mol/L RBC</p>
            <p>IDA: haemoglobin &lt; 110 g/L + two of three criteria: ferritin &lt; 12 &micro;g/L</p>
            <p>transferrin saturation &lt; 16 %, free erythrocyte protoporphyrin &gt; 1.77 &micro;mol/L RBC</p>
            <p>iron repletion: haemoglobin &ge; 110 g/L + two of three criteria: ferritin &ge; 12 &micro;g/L</p>
            <p>transferrin saturation &ge; 16 %, free erythrocyte protoporphyrin &le; 1.77 &micro;mol/L RBC</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Soemantri 1989</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&gt; 80<sup>th</sup> percentile of weight and height and mid-arm circumference &gt; 85<sup>th</sup> percentile of Indonesian growth standards, negative parasite egg count by stool examination after deworming treatment, no evidence of acute or chronic illness, clinical signs of malnutrition, physical handicaps, mental retardation, neurological dysfunction, or haematological disorders, consent of parent to participate in the study, IQ &gt; 75, absence of acute or severe morbidity</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>haemoglobin 111 to 119 g/L and transferrin saturation 13 to 19 % (to minimise the chances of an overlap between anaemic and non-anaemic groups)</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 110g/L and transferrin saturation &lt; 12 %</p>
            <p>non anaemia: haemoglobin &gt; 120 g/L and TS &lt; 20 %.</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Seshadri 1989b</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>haemoglobin 80 to 105 g/L, microcytic hypochromic erythrocyte morphology, weight-for-age &gt; 60 % of the Harvard standards, "draw-a-man" IQ &gt; 70</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia at initial assessment: haemoglobin &lt; 105 g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Seshadri 1989a</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children of low socioeconomic background 5 to 8 y of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>severe malnourishment: weight-for-age &gt; 60 % of the median value of National Center for Health Statistics standards</p>
            <p>anaemia: haemoglobin &lt; 110 g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Pollitt 1989</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <ul>
              <li>location specific criteria: non-malarial areas, &ge; 150 children per school, access to the main roads</li>
              <li>individual criteria: 108 to 144 mo of age, absence of AE Bart or haemoglobin H diseases, absence of abnormal haemoglobin E haemoglobinopathy</li>
            </ul>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>presence of thalassaemia major, presence of cyanotic congenital heart disease</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>IDA: haemoglobin &lt; 120 g/L plus two out of three of the following criteria: serum ferritin &lt; 10 &micro;g/L, transferrin saturation &lt; 16%, and free erythrocyte protoporphyrin &gt; 700 &micro;g/L RBC</p>
            <p>Iron depletion: haemoglobin &ge; 120 g/L plus two out of three of the following criteria: serum ferritin &lt; 10 &micro;g/L, transferrin saturation &lt; 16%, and free erythrocyte protoporphyrin &gt; 700 &micro;g/L RBC</p>
            <p>Iron repletion: haemoglobin &ge; 120 g/L plus two of the following three criteria: serum ferritin &ge; 10 &micro;g/L, transferrin saturation &ge; 16%, and free erythrocyte protporphyrin &le; 700 &micro;g/L RBC</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Mej&iacute;a 1988</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>haematocrit &gt; 1.5 standard deviations above normal value for age and place of residence</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>low ferritin: ferritin &lt; 12 &micro;g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Chwang 1988</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>no evidence of haematological-related diseases (thalassaemia, malaria, helminthiasis), nephritis, nephrosis, meningitis, encephalitis, measles, chicken pox, or other severe illness, nutritional deficiency symptoms, physical handicaps, or neurological abnormalities, negative egg count in stool examination after deworming treatment, &gt; 80<sup>th</sup> percentile of median weight for height and &gt; 85<sup>th</sup> percentile of median arm circumference for Indonesian growth curves of the respective measures</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>haemoglobin 1.11 to 1.19 g/L and transferrin saturation of 16 to 19 %</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Kashyap 1987</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children aged 8 to 15 y, monthly family income &le; 500 Indian Rupees (42 US Dollars), parental informed consent</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Aukett 1986</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children aged 17 to 19 mo, haemoglobin 8 to 11 g/dL</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 11 g/dL, severe anaemia: haemoglobin &lt; 8 g/dL</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Yip 1985</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>term infants who were seen for their routine 1-year health maintenance examination</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>preterm infants, infants for whom an appointment was scheduled for an illness</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 10.5 g/dL</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Soemantri 1985</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>primary school children, &gt; 80th percentile of weight and height, &gt; 85<sup>th</sup> percentile of mid-arm circumference of Indonesian growth standards, negative parasite egg count by stool examination after treatment of ancylostomiasis,no evidence of thalassaemia or malaria, other severe illness, nutrition deficiency, physical handicaps, and neurological abnormalities parental consent to participate in the study, IQ &gt; 75</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>11 &lt; haemoglobin &lt; 12 g/dL, 15.0 &lt; transferrin saturation &lt; 20.0 %</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &le; 11.0 g/dL and transferrin saturation &le; 15.0 %</p>
            <p>iron repletion: haemoglobin &ge; 12.0 g/dL and transferrin saturation &ge; 20 %</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Reeves 1985</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants 11 to 14 mo of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia, history of premature birth, or chronic illness</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &le; 10.5 g/dL</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Gopaldas 1985</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>boys 8 to 15 y from classes 4 to 7</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>haemoglobin adequacy: 12 g/dL (WHO cutoff) or 11 g/dL (Indian cutoff)</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Linpisarn 1984b</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>school children 7 to 12 y of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>positive for malaria or thalassaemia haemoglobinE type at screening</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>ID: haemoglobin &lt; 12 g/dL in pre-school children</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Linpisarn 1984a</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>pre-school children 2 to 6 y of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>positive for malaria or thalassaemia haemoglobinE type at screening</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>ID: haemoglobin &lt; 11 g/dL in pre-school children</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Das 1984</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;primary hematologic, cardiac, renal, hepatic disorders and other chronic infections or any other systemic diseases&rdquo;; severe anemia (haemoglobin &le; 6.0 g/dl)</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>severe anemia: haemoglobin &le; 6.0 g/d</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Charoenlarp 1980</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children 6 to 12 y of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>abnormal haemoglobin, high A<sub>2</sub> or PCV &lt; 0.24</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Bender G&ouml;tze 1980a</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>severe IDA</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>severe IDA: haemoglobin &lt; 7 g/dL</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Loria 1979</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Pereira 1978b</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>residents of an orphanage 2 to 5 y of age, signed informed consent from parents/legal guardians</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>presence of tuberculosis or other chronic diseases</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 110 g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Pereira 1978a</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>residents of an orphanage 2 to 5 y of age, signed informed consent from parents/legal guardians</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>presence of tuberculosis or other chronic diseases</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>anaemia: haemoglobin &lt; 110 g/L</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Charoenlarp 1973</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>schoolchildren 5 to 14 y of age, haematocrit levels within 3 SD of the initial values</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children taking tablets for &lt; 40 d</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Migasena 1972</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>children 6 mo to 6 y of age, haemoglobin &lt; 10 g/dL</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Fuerth 1972</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>infants who were members of the Kaiser Health Plan</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Burman 1972</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;Parents with home addresses in 8 wards in the North West part of the City of Bristol were invited to participate in the survey, provided that baby was born on certain prescribed dates between 15 June 1965 and 28 February 1966</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;Illegitimate babies, low birthweight infants (less than 2 - 5 kg), twins, and babies from known 'problem families' were excluded&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&ldquo;A proforma was completed and capillary blood samples were collected by a technician. If a patient did not attend a clinic, the technician visited the home. This process was repeated every 3 months but only data collected within 3 weeks either side of the predetermined day were included in the results used for analysis."</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Elwood 1970</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>"A 1-in-3 random sample of all the 14-year-old girls attending schools in the City of Cardiff, was chosen&rdquo;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td rowspan="3" style="vertical-align: top;">
            <p>Carter 1969</p>
          </td><td style="vertical-align: top;">
            <p>Inclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>boys between 11 and 18 y of age</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Exclusion criteria</p>
          </td><td style="vertical-align: top;">
            <p>females</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Diagnostic criteria</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
      </table>
    </div>
    <div>
      <table>
        <tr>
          <td style="vertical-align: top;">
            <p>
              <b>ASD</b>: autism spectrum disorder; <b>BMI</b>: body mass index; <b>CRP</b>: C-reactive protein; <b>d</b>: day(s); <b>h</b>: hour(s); <b>HAZ</b>: height-for-age Z-scores; <b>haemoglobin</b>: haemoglobin; <b>ID</b>: iron deficiency; <b>IDA</b>: iron deficiency anaemia; <b>MCH</b>: mean cell haemoglobin; <b>MCV</b>: mean corpuscular volume; <b>mo</b>: months; <b>PCV</b>: packed cell volume; <b>ppb</b>: parts per billion; <b>RBC</b>: red blood cell; <b>SD</b>: standard deviations; <b>SOL</b>: sleep onset latency; <b>UBT</b>: urea breath test; <b>WASO</b>: wake time after sleep onset; <b>WHO</b>: World Health Organization; <b>WHZ</b>: weight-for-height Z-scores; <b>wk</b>: week(s); <b>y</b>: year(s).</p>
            <p>&mdash;: denotes not reported</p>
          </td>
        </tr>
      </table>
    </div>
    <h2>References</h2>
    <ol>
      <li id="404935757088486172">
        <span publication-type="other"><span person-group-type="author"><span>World Health Organization</span></span>. <span>Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity</span>. <span>Vitamin and Mineral Nutrition Information System. Geneva, Switzerland: World Health Organization,</span> <span>2011</span>.</span>
      </li>
      <li id="433465774834182469">
        <span publication-type="journal"><span person-group-type="author"><span><span>Steinau</span> <span>S</span></span></span>. <span>iagnostic criteria in attention deficit hyperactivity disorder&ndash;changes in DSM 5</span>. <span>Frontiers in Psychiatry. 2013 May 30;4:49.</span> <span>2013</span>;<span>4</span>:<span>49</span>. [DOI: <a href="https://doi.org/10.3389/fpsyt.2013.00049">10.3389/fpsyt.2013.00049</a>]</span>
      </li>
      <li id="422043425252513842">
        <span publication-type="book"><span person-group-type="author"><span>American Psychiatric Association Task Force on DSM-IV</span></span>. <span>Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR</span>. Fourth Edition. <span>Washington, DC</span>: <span>American Psychiatric Association</span>, <span>2000</span>. </span>
      </li>
      <li id="422043526866081846">
        <span publication-type="book"><span person-group-type="author"><span><span>Lord</span> <span>C</span></span></span>. <span>Autism diagnostic observation schedule: ADOS: Manual</span>. <span>Western Psychological Services</span>, <span>2002</span>. </span>
      </li>
      <li id="422017777074348892">
        <span publication-type="journal"><span person-group-type="author"><span><span>Domell&ouml;f</span> <span>M</span></span>, <span><span>Dewey</span> <span>KG</span></span>, <span><span>L&ouml;nnerdal</span> <span>B</span></span>, <span><span>Cohen</span> <span>RJ</span></span>, <span><span>Hernell</span> <span>O</span></span></span>. <span>The diagnostic criteria for iron deficiency in infants should be reevaluated</span>. <span>Journal of Nutrition</span> <span>2002</span>;<span>132</span>(<span>12</span>):<span>3680-6</span>. [DOI: <a href="https://doi.org/https://doi.org/10.1093/jn/132.12.3680">https://doi.org/10.1093/jn/132.12.3680</a>]</span>
      </li>
    </ol>
  </body>
</html>
